Insulin Glargine (U-100) Vials and Loteprednol Etabonate
Determining the interaction of Insulin Glargine (U-100) Vials and Loteprednol Etabonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: loteprednol ophthalmic
Brand name: Alrex, Inveltys, Lotemax, Lotemax SM
Synonyms: Loteprednol (ophthalmic), Loteprednol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Vials-Loteprednol Eye Drops
- Insulin Glargine (U-100) Vials-Loteprednol Eye Drops 0.2%
- Insulin Glargine (U-100) Vials-Loteprednol Eye Drops 0.5% and 1%
- Insulin Glargine (U-100) Vials-Loteprednol Eye Gel
- Insulin Glargine (U-100) Vials-Loteprednol Eye Ointment
- Insulin Glargine (U-100) Vials-Loteprednol ophthalmic
- Loteprednol Etabonate-Insulin Glargine (U-300) Pens
- Loteprednol Etabonate-Insulin glargine and lixisenatide
- Loteprednol Etabonate-Insulin glargine and lixisenatide Subcutaneous
- Loteprednol Etabonate-Insulin glargine, recombinant Subcutaneous
- Loteprednol Etabonate-Insulin glulisine
- Loteprednol Etabonate-Insulin Glulisine (Cartridges and Pens)